Is There a Doctor in the House? FDA Bad Ad Program is Designed for...
Two days ago, I sent an email to FDA's "Bad Ad" program (email addr: BadAd@fda.hhs.gov) to cite a Pfizer iPhone App as a "Bad Ad" (see "Recipes 2 Go: Pfizer's LIPITOR-Branded...
Online Physician Communities Hold Promise, But Do They Deliver?
Doctors 2.0 and Pharma Marketing News is currently running the "Exploring the Doctor 2.0" survey (find it here), which asks respondents about the impact of New Technologies on healthcare, a subject...
Recipes 2 Go: Pfizer’s LIPITOR-Branded iPhone App. Is It an Ad FDA Should Review?
I just learned that Pfizer has developed an iPhone/iPad app that promotes LIPITOR, the drug company's off-patent lipid-lowering drug. The app is "Recipes 2 Go." It is the first pharmaceutical app...
Shire Seeks to Maintain YouTube “Loophole” in FDA’s Draft Guidelines for TV Ads
FDA has received several comments from the pharmaceutical industry regarding the agency's "Draft Guidance for Industry Direct-to-Consumer Television Advertisements." In past posts I reviewed comments from PhRMA (the drug industry U.S....
Sanofi Says Proposed FDA DTC Guidelines Would Effectively Kill TV Drug Ads
PhRMA is itching to challenge FDA's authority to regulate DTC advertising in front of the Supreme Court, arguing that recent "Draft FDA Guidance on PreDissemination Review of TV Direct-to-Consumer Ads" (find...
PhRMA Demands that FDA “Cabin” Its Discretion to Regulate DTC Ads
In a 20-page comment submitted to the FDA on May 14, 2012, the Pharmaceutical Research and Manufacturers of America (PhRMA), advised the FDA to "proceed cautiously and in a manner that...
Drugs are Losing the Battle Against Heart Disease. Here’s Why.
The percentage of the U.S. population taking at least one prescription drug during the past 30 days increased from 38% in 1988–1994 to 48% in 2005–2008. During the same period, the...
AstraZeneca’s Timely CRESTOR Branded Blog Post: Did It Violate Its Own Policy?
It's unusual for a pharmaceutical company to mention a product by brand name on its corporate blog. It's even more unusual to mention BOTH the product AND its indication -- because...
Pfizer Throws In the Lipitor Marketing Towel. Repercussions in Job Market Will Be Swift
Despite Pfizer's heroic and unprecedented effort to maintain Lipitor's market share after expiry last November and after spending "more than $87 million promoting the medicine, the world's biggest drug company is...
